Laura Pitlik - 16 Aug 2022 Form 4 Insider Report for Arcadia Biosciences, Inc. (RKDA)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	RKDA	Stock Option (right to buy)	Award	$0	+23,000	+18%	$0.000000	152,000	16 Aug 2022	Common Stock	23,000	$0.9400	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	The option vests in two equal installments occurring on the first, and second anniversary of the date of grant.

None